Wnt-signaling activating bi-specific full-length human antibody (Surrozen)

N/A

Report date: 2025/03/20 09:55:58

Base Information

Drug NameWnt-signaling activating bi-specific full-length human antibody (Surrozen)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionCatenin beta 1 stimulants

TargetsCatenin beta 1

Therapy Area/IndicationsHearing Loss

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSurrozen Inc

China Registration ClassN/A

Develop Information

Active CompaniesSurrozen Inc

Inactive CompaniesN/A

Active IndicationsHearing Loss

Inactive IndicationsN/A

Other Information

ATC CodeN/A